KYGEVVI 2 g/2 g, powder for oral solution 30 sachets
Active ingredients: DOXRIBTIMINE, DOXÉCITINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral solution30 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KYGEVVI 2 g/2 g, poudre pour solution buvable
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 30 sachet(s) polyéthylène basse densité (PEBD) aluminium polyéthylène téréphtalate (PET)
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Jul 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
67232080CIP73033524CIP133400930335246Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DOXRIBTIMINEpoudre | 2 g · un sachet | SA |
| DOXÉCITINEpoudre | 2 g · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.